axitinib
axitinib: 7 clinical trials tracked.
axitinib evidence translation
What we can confirm
7 tracked trials
What it means
What to watch
Prepared research question
What is verified about axitinib, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 4 study sponsors
Clinical Trials (7)
Phase III Double Blinded Trial of Immune-Based Therapy With a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BioFront Trial]
Primary endpoint: Progression-free survival (PFS)
A Phase 1/2 Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Primary endpoint: Part 1: Number of Participants With Dose-limiting Toxicities (DLTs)
Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)
Primary endpoint: Nephrectomy and radiographic progression-free survival (nrPFS)
AVELUMAB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED AVELUMAB CLINICAL STUDIES.
Primary endpoint: Number of participants with adverse events leading to permanent discontinuation of study intervention
Phase 2 Study of Axitinib + Ipilimumab in Advanced Melanoma
Primary endpoint: Overall Response Rate
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial
Primary endpoint: Objective response rate defined as the number of patients with complete response or partial response
A Dutch National Study on Behalf of the CPCT to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to Determine the Potential Efficacy in Treatment of Advanced Cancers With a Known Molecular Profile
Primary endpoint: Percentage of patients that are treated based on their molecular tumor profile